Clinical Trial Update: Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating potential drug interactions among HRS-9813, pirfenidone, and nintedanib in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• HRS-9813
• Nintedanib (nintedanib)
• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Pulmonary Fibrosis | Phase 1 | Status: NOT_YET_RECRUITING